INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Trexquant Investment LP's Holding History (CIK: 0001633445)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 52,585 Value ($000) $4,392 Avg Close Range
Q3 2024
Shares 99,549 Value ($000) $7,284 Avg Close Range
Q2 2024
Shares 78,537 Value ($000) $5,379 Avg Close Range
Q1 2024
Shares 72,448 Value ($000) $5,013 Avg Close Range
Q4 2023
Shares 78,876 Value ($000) $5,649 Avg Close Range
Q3 2023
Shares 75,841 Value ($000) $3,951 Avg Close Range
Q2 2023
Shares 44,586 Value ($000) $2,823 Avg Close Range
Q1 2023
Shares 32,893 Value ($000) $1,781 Avg Close Range
Q4 2022
Shares 32,724 Value ($000) $1,732 Avg Close Range
Q2 2022
Shares 8,360 Value ($000) $477 Avg Close Range
Q2 2021
Shares 15,366 Value ($000) $627 Avg Close Range
Q1 2020
Shares 39,986 Value ($000) $615 Avg Close Range
Q3 2019
Shares 18,383 Value ($000) $137 Avg Close Range
Q2 2018
Shares 14,096 Value ($000) $249 Avg Close Range
Q1 2018
Shares 17,780 Value ($000) $374 Avg Close Range
Q4 2017
Shares 37,203 Value ($000) $539 Avg Close Range
Q3 2017
Shares 32,176 Value ($000) $508 Avg Close Range
Q1 2017
Shares 23,652 Value ($000) $384 Avg Close Range
Q2 2016
Shares 8,581 Value ($000) $333 Avg Close Range
Q2 2015
Shares 21,200 Value ($000) $677 Avg Close Range